169343 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
ABSORBENT ARTICLE HAVING VAGINAL DISCHARGE TEST STRIP, AND VAGINAL DISCHARGE TEST STRIP FOR USE IN ABSORBENT ARTICLE
#2DIAGNOSTIC DEVICE FOR DETECTING AND/OR IDENTIFYING A TARGET ANALYTE FROM A LIQUID SAMPLE
#3ASSAY DEVICE
#4COMPOSITION, AQUEOUS SOLUTION OF ENDOCRINE PROTEIN, ADSORPTION INHIBITOR, METHOD FOR SUPPRESSING ADSORPTION OF ENDOCRINE PROTEIN, METHOD FOR MEASURING AMOUNT OF ENDOCRINE PROTEIN, AND REAGENT KIT FOR MEASURING ENDOCRINE PROTEIN
#5IMPROVED ASSAY COMPOSITIONS AND METHODS
#6NANOROBOT FOR RECOGNITION OF PROTEINS IN MEDIUMS AT ULTRA-LOW CONCENTRATION
#7LATERAL FLOW TEST STRIP READERS, CARTRIDGES AND RELATED METHODS
#8Epitope-Specific hCG Binding Aptamers and Applications Thereof
#9IMMUNOASSAY FOR DETECTING BIOLOGICALLY ACTIVE PROTEINS
#10COMPOSITIONS FOR ENDOMETRIOSIS ASSESSMENT HAVING IMPROVED SPECIFICITY
#11MOLECULES FOR DETECTION OF BIOMARKERS IN BODILY EMISSIONS
#12QUANTITATIVE HORMONE AND CHEMICAL ANALYTE TEST RESULT SYSTEMS AND METHODS
#13CHEMILUMINESCENT SUBSTRATE SOLUTION AND CHEMILUMINESCENCE DETECTION METHOD
#14DIAGNOSTIC TEST DEVICE WITH IMPROVED USE AND VISUAL DETECTION OF AN ANALOG TEST RESULT
#15CAPTURE COMPOSITIONS
#16DEVICES AND METHODS FOR DETECTING ANALYTES
#17CAR T-CELL THERAPY DIRECTED TO LHR FOR THE TREATMENT OF SOLID TUMORS
#18TEST STRIP FOR DETECTING HUMAN CHORIONIC GONADOTROPIN IN SALIVA AND PREPARATION METHOD THEREOF
#19NOVEL IMMUNODIAGNOSTIC DEVICE FOR DETERMINING NORMAL AND ABNORMAL PREGNANCY BY MEASURING DISTRIBUTION RATIO OF BETA CORE FRAGMENT HCG
#20Antibody, Kit, Detection Method and Sample Analyzer for Detecting Thyroid Stimulating Hormone
#21DEVICES, SYSTEMS AND METHODS FOR DETECTION OF BETA SUBUNIT OF LUTEINIZING HORMONE
#22SYSTEMS AND METHODS FOR DETERMINING UCH-L1, GFAP, AND OTHER BIOMARKERS IN BLOOD SAMPLES
#23FLUID SAMPLE CONCENTRATOR
#24TEST DEVICE FOR DETECTING ANALYTE IN LIQUID SAMPLE
#25TESTING METHOD AND KIT
#26A REUSABLE TEST DEVICE
#27ULTRA-FAST AND HIGHLY-SENSITIVE CHEMILUMINESCENT IMMUNOASSAY METHOD FOR DETECTING THYROID STIMULATING HORMONE
#28Quantitative hormone and chemical analyte test result systems and methods
#29TARGET ANALYTE DETECTION METHOD BASED ON PROXIMITY PROTEOLYSIS REACTION
#30Ultra-fast and highly-sensitive chemiluminescent immunoassay method for detecting thyroid stimulating hormone
#31COMPOSITIONS AND METHODS FOR DETECTING AUTOANTIBODIES
#32SYSTEM AND METHOD FOR COLLECTION AND DISSEMINATION OF BIOLOGIC SAMPLE TEST RESULTS DATA
#33SYSTEM FOR EVALUATING URINE FOR THE PRESENCE OR ABSENCE OF PREGNANEDIOL GLUCURONIDE AND OTHER HORMONES AND ANALYTES
#34LATERAL FLOW IMMUNOASSAY DEVICES WITH DYNAMIC TRACKING AND METHODS OF USING THE SAME
#35A Newborn Metabolic Vulnerability Model For Identifying Preterm Infants At Risk Of Adverse Outcomes, And Uses Thereof
#36KINETIC MODULATION FOR MAGNETIC ANALYTE DETECTION
#37POLYPEPTIDE, MULTIMER, SOLID PHASE, MEASUREMENT METHOD FOR TEST SUBSTANCE, AND REAGENT KIT
#38METHOD FOR TESTING DIFFERENT HORMONES BASED ON DIFFERENT TIME PERIODS OF PREGNANCY PREPARATION
#39Non-invasive analyte sensor with temperature compensation
#40Detection and Treatment of Pregnancy Complications Comprising Determining Sialyl Lewis Antigens and Administering hCG
#41COMPOSITIONS FOR ENDOMETRIOSIS ASSESSMENT HAVING IMPROVED SPECIFICITY
#42OVULATION MONITORING PLATFORM
#43Quantitative hormone and chemical analyte test result systems and methods
#44METHOD FOR ANALYZING DEGARELIX AND ASSOCIATED PRODUCTS
#45Apparatus and method for personalized hormonal diagnostics and therapy
#46METHODS AND SYSTEMS FOR MENSTRUALOME ANALYSIS
#47Detection and Treatment of Conditions Related to Luteinizing Hormone/Follicle-Stimulating Hormone (LH/FSH) Levels
#48ALGORITHM FOR IMPROVING OVARIAN STIMULATION
#49SYSTEMS AND METHODS FOR MENSTRUAL CYCLE TESTING
#50CLEAN SCREEN CONTACTLESS ANALYTE DETECTION TEST
#51LATERAL FLOW TEST STRIP READERS, CARTRIDGES AND RELATED METHODS
#52ASSAY DEVICE
#53Method and system for detecting analyte of interest using magnetic field sensor and magnetic particles
#54PAPER LATERAL FLOW IMMUNOASSAY
#55IMMUNOCHROMATOGRAPHY STRIP FOR PREGNANCY DIAGNOSIS WITH MULTIPLE TEST LINES, AND PREGNANCY DIAGNOSIS KIT COMPRISING SAME
#56Method for detection and interpretation of results indicated on a photographed diagnostic test
#57System for the ovarian reserve function assessment of subjects
#58Diagnostic test device with improved use and visual detection of an analog test result
#59CAR T-CELL THERAPY DIRECTED TO LHR FOR THE TREATMENT OF SOLID TUMORS
#60SYSTEM AND METHOD FOR DIGITAL REMOTE PRIMARY, SECONDARY, AND TERTIARY COLOR CALIBRATION VIA SMART DEVICE IN ANALYSIS OF MEDICAL TEST RESULTS
#61Method for evaluating urine of a subject to estimate the fertile window by evaluating for the presence of analytes of estrogen and progesterone
#62Quantitative hormone and chemical analyte test result systems and methods
#63CAPTURE COMPOSITIONS
#64System for evaluating urine for the presence or absence of pregnanediol glucuronide and other hormones and analytes
#65Method for evaluating urine of a subject to estimate the fertile window
#66METHODS, DEVICES, AND SYSTEMS FOR DETECTING ANALYTE LEVELS
#67MEDICAL APPARATUS FOR TESTING FOR MEDICAL CONDITIONS INCLUDING ZIKA AND PREGNANCY
#68Diagnostic Devices And Methods
#69COMPUTER-IMPLEMENTED METHODS OF ESTIMATING A PROBABILITY OF LIVE BIRTH IN AN INFERTILITY SUBJECT, COMPUTER-READABLE MEDIA, AND DIAGNOSTICS
#70MULTIVALENT MONO- OR BISPECIFIC RECOMBINANT ANTIBODIES FOR ANALYTIC PURPOSE
#71NOVEL PREGNANCY DIAGNOSIS DEVICE INCLUDING BETA-CORE FRAGMENT HCG AS MARKER
#72Compositions and methods for detecting autoantibodies
#73BREAST CANCER DETECTION KIT USING SALIVA AND BREAST CANCER DETECTION METHOD USING SAME, AND FERTILE WINDOW DETECTION KIT USING SALIVA AND FERTILE WINDOW DETECTION METHOD USING SAME
#74Monthly Cycle Fitness Optimizer
#75NON-OPTICAL LABEL-FREE BIOMOLECULAR DETECTION AT ELECTRIALLY DISPLACED LIQUID INTERFACES USING INTERFACIAL ELECTROKINETIC TRANSDUCTION (IET)
#76Detection and treatment of pregnancy complications comprising determining sialyl Lewis antigens and administering hCG
#77Method and system for linking devices
#78Detection device capable of visual test results
#79System of evaluating corpus luteum function by recurrently evaluating progesterone non-serum bodily fluids on multiple days
#80DEVICES FOR PREGNANCY DETECTION AND CORRESPONDING METHODS THEREOF
#81Dual Indicator Light Pregnancy Testing Device
#82METHODS FOR ASSESSING THE PROBABILITY OF ACHIEVING ONGOING PREGNANCY AND INFORMING TREATMENT THEREFROM
#83System and method for digital remote primary, secondary, and tertiary color calibration via smart device in analysis of medical test results
#84SAMPLE CONTAINER WITH INTEGRATED TEST STRIP
#85Method and device for estimation of ovulation date
#86Pregnancy test device and method
#87SYSTEMS AND METHODS FOR EVALUATING INTERSTITIAL FLUIDS
#88PREGNANCY TEST AND KEEPSAKE DEVICE AND METHOD OF USE THEREOF
#89SAFE BLOOD PREGNANCY TEST AT HOME
#90Medical apparatus for testing for medical conditions including zika and pregnancy
#91Composition comprising recombinant human thyroid stimulating hormone and method for producing recombinant human thyroid stimulating hormone
#92Wearable digital device for personal health use for saliva, urine and blood testing and mobile wrist watch powered by user body
#93Integrated diagnostic device
#94Optical assay device with pneumatic sample actuation
#95Detection and treatment of pregnancy complications comprising determining sialyl Lewis antigens and administering hCG
#96LATERAL FLOW ASSAY RATIO TEST
#97Device and method of detecting TSH
#98Immunochromatographic test piece
#99Methods for chemotaxis / redox driven separation of X and Y chromosome bearing sperm and their insemination in gender specific menstrual cycles
#100Bioassay Method for Antibody Against Thyroid-Stimulating Hormone Receptor, Measurement Kit for the Antibody, and Novel Genetically Modified Cell for Use in the Bioassay Method or the Measurement Kit
#101Electronic analyte assaying device
#102Lateral flow assays using two dimensional features
#103Water dispersible assays
#104Detection of autoantibodies against the TSH receptor
#105Lateral flow membrane designed for multiparameter readouts and compact multiparameter lateral flow immunoassay device comprising the same
#106Molecular nets and devices for capturing analytes including exosomes
#107Diagnostic detection device and method for detecting human chorionic gonadotropin or derivative in urine, blood, saliva, or other body fluid
#108Lateral flow assays with thermal contrast readers
#109Car t-cell therapy directed to LHR for the treatment of solid tumors
#110METHODS AND SYSTEMS FOR ASSESSING FERTILITY BASED ON SUBCLINICAL GENETIC FACTORS
#111System and method for image analysis of medical test results
#112System and method for immediate health assessment response system
#113System and method for collection and dissemination of biologic sample test results data
#114Quality control system and kit for automated ELISA devices
#115Pregnancy test device and method
#116Methods and Compositions for Personalized Medicine by Point-of-Care Devices for FSH, LH, HCG and BNP
#117Diagnostic devices and methods for mitigating hook effect and use thereof
#118Lateral Flow Analyte Detection
#119Methods Of Detecting Ectopic Pregnancy
#120Sample container with integrated test strip
#121FERTILITY AND PREGNANCY MONITORING DEVICE AND METHOD
#122OPTICAL READER SYSTEMS AND LATERAL FLOW ASSAYS
#123ELECTRONIC ANALYTE ASSAYING DEVICE
#124Electronic analyte assaying device
#125Optical assay device with pneumatic sample actuation
#126INTELLIGENT TEST STRIP DETECTION DEVICE AND METHOD THEREOF
#127Lateral flow membrane arrangement and lateral flow immunoassay device comprising the same
#128SYSTEMS AND METHODS FOR OVULATION STATUS AND PREGNANCY DETECTION
#129METHODS FOR PREDICTING EMBRYO VIABILITY
#130APPARATUSES, METHODS, AND SYSTEMS FOR HOME MONITORING OF PHYSIOLOGICAL STATES AND CONDITIONS
#131Assay Device With Shared Zones
#132TSH antibodies for point-of-care immunoassay formats
#133TSH immunoassays and processes for performing TSH immunoassays in the presence of endogenous contaminants in restricted wash formats
#134Device and method of detecting TSH
#135System and method for deriving parameters for homeostatic feedback control of an individual
#136DETECTION AND TREATMENT OF PREGNANCY COMPLICATIONS
#137COMPOSITION OF CONJUGATES AND USES
#138DIAGNOSTIC DEVICES AND METHODS
#139Assay devices with integrated sample dilution and dilution verification and methods of using same
#140Ratiometric immunoassay method and blood testing device
#141Ratiometric immunoassay method and blood testing device
#142Devices and methods for electronic analyte assaying
#143Diagnostic devices and methods
#144LATERAL FLOW ASSAYS USING DNA DENDRIMERS
#145Methods and Compositions for Personalized Medicine by Point-of-Care Devices for FSH, LH, HCG and BNP
#146Device for determining at least one analyte capable of being contained in a liquid sample
#147At-home blood pregnancy test kit
#148Method for the Selection of Serum Biomarkers of Epigenetic Alterations, Particularly of Global Hypomethylation and Their Uses
#149Pregnancy test device and method
#150At-Home Blood Pregnancy Test Kit
#151Maternal biomarkers for gestational diabetes
#152Electronic analyte assaying device
#153METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY HCG ASSAY
#154Electronic Pregnancy Test Device
#155Devices for capturing analyte
#156Use of female mammal's urine for determination of fetal gender related characteristics
#157Methods for predicting pregnancy outcome in a subject by hCG assay
#158OVARIAN MARKERS OF FOLLICULAR MATURITY AND USES THEREOF
#159Fluidic indicator device
#160Method and kit for detecting the preovulatory LH peak
#161Methods for predicting pregnancy outcome in a subject by HCG assay
#162Maternal biomarkers for gestational diabetes
#163Crystal structure
#164TSH immunoassays employing scavenging reagents for cross-reacting endocrine glycoprotein hormone analogues
#165Lateral flow assays using DNA dendrimers
#166Assay device
#167Maternal biomarkers for gestational diabetes
#168Methods and Compositions for Diagnosis of Non-Viable Early Pregnancy
#169Lateral flow assays using two dimensional features
#170Lateral flow assays using two dimensional features
#171Optical assay device with pneumatic sample actuation
#172Diagnostic detection device
#173Diagnostic detection devices and methods
#174Rapidly disintegrating films for delivery of pharmaceutical or cosmetic agents
#175Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
#176Device and method of detecting TSH
#177Compositions and methods for detecting autoantibodies
#178METHOD FOR QUANTIFYING THE EXTENT OF HUMAN-INTRODUCED VARIABILITY IN MEDICAL TEST DATA
#179REAGENT COMPOSITION FOR IMMUNOCHROMATOGRAPHY
#180Methods for predicting pregnancy outcome in a subject by hCG assay
#181METHODS AND KITS FOR DECREASING INTERFERENCES IN PLASMA OR SERUM CONTAINING ASSAY SAMPLES OF SPECIFIC BINDING ASSAYS
#182Hyperglycosylated hCG detection device
#183TSH immunoassays employing scavenging reagents for cross-reacting endocrine glycoprotein hormone analogues
#184TSH immunoassays and processes for performing TSH immunoassays in the presence of endogenous contaminants in restricted wash formats
#185TSH antibodies for point-of-care immunoassay formats
#186Monoclonal antibodies against gonadotropin-releasing hormone receptor
#187Monoclonal thyroid stimulating or blocking antibodies, peptide sequences corresponding to their variable regions, and their uses in diagnostic, preventive and therapeutic medicine
#188Methods for reducing GnRH-positive tumor cell proliferation using the GnRH antagonist IN3
#189Methods and compositions for diagnosis of ectopic pregnancy
#190Multiple Assay Device
#191Lateral flow assays using two dimensional features
#192BIOASSAY METHOD FOR ANTIBODY AGAINST THYROID-STIMULATING HORMONE RECEPTOR, MEASUREMENT KIT FOR THE ANTIBODY, AND NOVEL GENETICALLY MODIFIED CELL FOR USE IN THE BIOASSAY METHOD OR THE MEASUREMENT KIT
#193Assay devices with integrated sample dilution and dilution verification and methods of using same
#194Ratiometric immunoassay method and blood testing device
#195GFP FUSION PROTEINS AND THEIR USE
#196Fluidic indicator device
#197CRYSTAL STRUCTURE
#198Ovulation predictor test
#199Electronic analyte assaying device
#200Assay reader, device and method of measuring HCG
#201ASSAY DEVICE WITH SHARED ZONES
#202Methods for predicting pregnancy outcome in a subject by hCG assay
#203Determination of the amount of hLHB core fragment in a sample from a subject and uses thereof
#204Methods for predicting pregnancy outcome in a subject by hCG assay
#205Methods and apparatus for screening for chromosomal abnormalities
#206Use of female mammal's urine for determination of fetal gender related characteristics
#207Nucleic acid ligand complexes
#208Hyperglycosylated hCG detection device
#209Methods for predicting pregnancy outcome in a subject by hCG assay
#210METHODS AND KITS FOR DECREASING INTERFERENCES IN PLASMA OR SERUM CONTAINING ASSAY SAMPLES OF SPECIFIC BINDING ASSAYS
#211Monoclonal antibodies against gonadotropin-releasing hormone receptor
#212Assay device
#213COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL
#214Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
#215Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
#216COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL
#217COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL
#218Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
#219Methods for identifying GLP-1 secretagogues
#220COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL
#221Crystal structure of thyroid stimulating hormone receptor
#222Assay device
#223METHODS FOR REDUCING GNRH-POSITIVE TUMOR CELL PROLIFERATION
#224COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL
#225PREGNANCY TESTING METHOD
#226METHOD FOR ANTENATAL ESTIMATION OF RISK OF ANEUPLOIDY
#227Innovative TSH-R-Ab-kit
#228DEVICE AND METHOD FOR DETECTION OF A PREGNANCY ASSOCIATED HORMONE
#229Human glycoprotein hormone superagonists and uses thereof
#230Diagnose device for measuring the ratio of proteins with similar structure
#231Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
#232Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto
#233Multiple Assay Device
#234Disintegratable films for diagnostic devices
#235Double brilliance beta-arrestin: a biosensor for monitoring the activity of receptors and signalling molecules, and method of using same
#236Method Of Diagnosing A Body Weight Condition Or Predisposition
#237High Affinity Nucleic Acid Ligands To Lectins
#238Methods and systems for quantification of peptides and other analytes
#239METHOD OF HIGH SENSITIVE IMMUNOASSAY
#240SANDWICH IMMUNOASSAY AND METHOD OF DETECTING AN ANTIGEN BY USING THE SAME
#241Methods for predicting embryo viability
#242Assay device with shared zones
#243Monoclonal thyroid stimulating or blocking antibodies, peptide sequences corresponding to their variable regions, and their uses in diagnostic, preventive and therapeutic medicine
#244Human G Protein-Coupled Receptor and Modulators Thereof for the Treatment of Hyperglycemia and Related Disorders
#245Methods of screening for compounds which bind G protein-coupled receptors
#246Disintegratable films for diagnostic devices
#247G-PROTEIN COUPLED RECEPTORS HIGH-THROUGHPUT FUNCTIONAL ASSAY
#248Lateral-Flow Test Device Providing Improved Test Result Validity
#249Test Methods and Devices
#250Method for determining hCG levels in fluid samples
#251Method for the quantitative determination of poloxamers
#252Pre-Implantation Genetic Diagnosis Test
#253Assays
#254Methods for predicting preganancy outcome in a subject by hCG assay
#255Biologically active synthetic thyrotropin and cloned gene for producing same
#256Fluidic Indicator Device
#257Methods for inhibiting osteoclastic bone resorption and bone loss comprising administration of an anti-FSH or anti-FSHR antibody
#258Pregnancy test device
#259Quantitative lateral flow assays and devices
#260Human G protein-coupled receptor and modulators thereof for the treatment of cardiovascular disorders
#261Reduction of platelet interference in plasma assay samples
#262Biologically active synthetic thyrotropin and cloned gene for producing same
#263Multi-analyte diagnostic test for thyroid disorders
#264Methods and kits for decreasing interferences in plasma or serum containing assay samples of specific binding assays
#265Methods and apparatus for screening for chromosomal abmormalities
#266Method for cleaving and deglycosylating antibodies to promote ligand binding
#267USE OF CORTICOTROPH-DERIVED GLYCOPROTEIN HORMONE TO TREAT INFLAMMATION AND POTENTIATE GLUCOCORTICOID ACTION
#268Method for searching myelin using gonadotropin-releasing hormone receptors as a new biomarker
#269Assessing Ovarian Reserve
#270Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
#271Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
#272Method and means for the determination of defined states or modifications in the mucus of the uterus or in the epithelium of other organs
#273Methods for predicting pregnancy outcome in a subject by hCG assay
#274Biologically active synthetic thyrotropin and cloned gene for producing same
#275Methods for determination of an analyte
#276Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor
#277Menopause stage monitor
#278Lysophosphatidic acid receptor
#279At-home cancer test
#280GFP fusion proteins and their use
#281Sandwich immunoassay for identifying partial proANP peptides
#282Methods for identification of modulators of OSGPR116 activity, and their use in the treatment of disease
#283Identification of TSH receptor autoantibodies using affinity-purified antibodies
#284Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
#285Biologically active synthetic thyrotropin and cloned gene for producing same
#286Novel G protein-coupled receptor encoding gene and diagnostic uses therefor
#287Method of detecting early pregnancy at high accuracy by measuring hCG and hyperglycosylated hCG concentrations equally
#288Tenascin-C nucleic acid ligands
#289Systematic evolution of ligands by exponential enrichment: Chemi-SELEX
#290High affinity TGFbeta nucleic acid ligands and inhibitors
#291Method for cleaving and deglycosylating antibodies to promote ligand binding
#292Method and apparatus for predicting pregnancy outcome
#293Test device and method for colored particle immunoassay
#294Methods and compositions to promote bone homestasis
#295Methods and compositions to promote bone homeostasis
#296Assays
#297Determining the estimated date of embryo implantation and related dates
#298Quantitative lateral flow assays and devices
#299Nucleic acid ligand complexes
#300Substituted pyrimidinones and pyrimidinthiones